[1]
Dijkshoorn L,
Nemec A,
Seifert H. An increasing threat in hospitals: multidrug-resistant
Acinetobacter baumannii. Nat Rev Microbiol 2007; 5(12): 939-51.
[2]
Bahador A,
Taheri M,
Pourakbari B,
Hashemizadeh Z,
Rostami H,
Mansoori N,
Raoofian R. Emergence of rifampicin, tigecycline, and colistin-resistant
Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants. Microb Drug Resist 2013; 19(5): 397-406.
[3]
Livermore DM1,
Woodford N. Carbapenemases: a problem in waiting? Curr Opin Microbiol 2000; 3(5): 489-95.
[4]
Bonomo RA,
Szabo D. Mechanisms of multidrug resistance in
Acinetobacter species and
Pseudomonas aeruginosa.
Clin Infect Dis 2006; 43 Suppl 2: S49-56.
[5]
Kramer A,
Schwebke I,
Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review.
BMC Infect Dis 2006; 6: 130.
[6]
Munoz-Price LS,
Weinstein RA.
Acinetobacter infection. N
Engl J Med 2008; 358(12): 1271-81.
[8]
Hornef MW,
Wick MJ,
Rhen M,
Normark S. Bacterial strategies for overcoming host innate and adaptive immune responses.
Nat Immunol 2002; 3(11): 1033-40.
[9]
Sauer FG,
Barnhart M,
Choudhury D,
Knight SD,
Waksman G,
Hultgren SJ. Chaperone-assisted pilus assembly and bacterial attachment.
Curr Opin Struct Biol 2000; 10(5): 548-56.
[10]
Grijpstra J,
Arenas J,
Rutten L,
Tommassen J. Autotransporter secretion: varying on a theme.
Res Microbiol 2013; 164(6): 562-82.
[11]
Benz I,
Schmidt MA. Structures and functions of autotransporter proteins in microbial pathogens.
Int J Med Microbiol 2011; 301(6): 461-8.
[12]
Henderson IR,
Navarro-Garcia F,
Desvaux M,
Fernandez RC,
Ala'Aldeen D. Type V protein secretion pathway: the autotransporter story.
Microbiol Mol Biol Rev 2004; 68(4): 692-744.
[13]
Balder R,
Hassel J,
Lipski S,
Lafontaine ER.
Moraxella catarrhalis strain O35E expresses two filamentous hemagglutinin-like proteins that mediate adherence to human epithelial cells.
Infect Immun 2007; 75(6): 2765-75.
[14] Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. 2 ed. New York: Cold Spring Harbor Laboratory Press, 1989.
[15]
Plamondon P,
Luke NR,
Campagnari AA. Identification of a novel two-partner secretion locus in
Moraxella catarrhalis.
Infect Immun 2007; 75(6): 2929-36.
[16]
Brossard KA,
Campagnari AA. The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells.
Infect Immun 2012; 80(1): 228-33.
[17]
Levin AS,
Levy CE,
Manrique AE,
Medeiros EA,
Costa SF. Severe nosocomial infections with imipenem-resistant
Acinetobacter baumannii treated with ampicillin/sulbactam.
Int J Antimicrob Agents 2003; 21(1): 58-62.
[18]
Henderson IR,
Nataro JP. Virulence functions of autotransporter proteins.
Infect Immun 2001;
69(3): 1231-43.
[19]
Henderson IR,
Cappello R,
Nataro JP. Autotransporter proteins, evolution and redefining protein secretion.
Trends Microbiol 2000; 8(12): 529-32.
[20]
Wells TJ,
Tree JJ,
Ulett GC,
Schembri MA. Autotransporter proteins: novel targets at the bacterial cell surface.
FEMS Microbiol Lett 2007; 274(2): 163-72.
[21]
Choi PS,
Dawson AJ,
Bernstein HD. Characterization of a novel two-partner secretion system in
Escherichia coli O157:H7.
J Bacteriol 2007; 189(9): 3452-61.
[22]
Piatti G. Identification of immunodominant epitopes in the filamentous hemagglutinin of
Bordetella pertussis.
FEMS Immunol Med Microbiol 1999; 23(3): 235-41.
[23]
Desrousseaux C,
Sautou V,
Descamps S,
Traoré O. Modification of the surfaces of medical devices to prevent microbial adhesion and biofilm formation.
J Hosp Infect 2013; 85(2):87-93.